Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against...
AMG 334 20160172 Pediatric Migraine PK Study.
The reason for this study is to see how effective and safe the study drug known as lasmiditan is in...
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and...
To evaluate the effect of erenumab compared to placebo on disability in employed subjects with episodic migraine (EM) who have...
The purpose of this study is to evaluate the efficacy and safety of erenumab in patients with chronic migraine in...
The main purpose of this study is to determine the safety and efficacy of the study drug galcanezumab in participants...
English (USA)